Clinical Trials Related to Orelabrutinib

Related studies linked through entity extraction aliases.

A Multicenter, Prospective, Open-Label, Randomized Controlled Clinical Study of Orelabrutinib Combined With Obinutuzumab and Lenalidomide Versus Obinutuzumab Plus Chemotherapy for Treatment-Naive Follicular Lymphoma

Status: NOT_YET_RECRUITING
Phase: PHASE3

Orelabrutinib Combined With Obinutuzumab and Short-Course Venetoclax in Patients With Treatment-Naïve Mantle Cell Lymphoma (MCL)

Status: RECRUITING
Phase: PHASE2

A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

Status: RECRUITING
Phase: PHASE3

Orelabrutinib Plus Lisaftoclax and Rituximab in Untreated Mantle Cell Lymphoma With High-Risk Disease

Status: RECRUITING
Phase: PHASE2

A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

Status: RECRUITING
Phase: PHASE3